Eradivir
PrivateLast Round
Private Placement
Oct 7, 2025
Total Funding Raised
$11.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Eradivir is a biotechnology company that develops immunotherapies to treat viral infections and other diseases using a proprietary small-molecule targeting platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eradivir Comparables
Compare Eradivir with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Via Nova Therapeutics | 84% | |
| Cocrystal Pharma Inc | 79% | |
| Astremiha Therapeutics | 77% | |
Eradivir Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Oct 7, 2025 | ||||
| Series A | Sep 23, 2024 | ||||
| Grant | Sep 18, 2023 | ||||
| Grant | Feb 15, 2021 | ||||
| Seed | Apr 15, 2020 |
Eradivir Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Administration for Strategic Preparedness and Response | Grant |
| Research Bridge Partners | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 54% MoM.
- May 27, 2026
Grew 36% QoQ, from 25 to 34 employees.
Eradivir Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eradivir's valuation, stock price, and market status.